Key facts
- PROK - PROKIDNEY CORP. has 25 insiders with reported activity on this page.
- Net insider value flow over the last year: -$1,884,577.
- Recent transaction rows are available for direct filing-level review.
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Net insider flow leans to selling over the last 12 months. Net value: -$1,884,577.
$0
Shares: 0
Insiders: 0
$1,884,577
Shares: 757,162
Insiders: 1
-$1,884,577
Shares: -757,162
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 757,162 | $0 | $1,884,577 | -$1,884,577 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tolerantia, LLC |
13D/G
|
36%
|
$93,004,165
106,901,339 shares
|
-$3,326,877 | 03 Jun 2025 |
| Control Empresarial de Capitales S.A. de C.V. |
13D/G
3/4/5
Other*, 10%+ Owner
|
36%
|
$132,052,942
73,842,723 shares
|
$0 | 28 Apr 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
6%
|
$19,510,759
8,519,982 shares
|
$0 | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
1.4%
from 13D/G
|
$2,482,938
1,387,116 shares
|
— | 31 Mar 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
6%
|
$22,090,866
12,341,266 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.1%
|
$4,066,123
2,271,577 shares
|
— | 31 Mar 2026 |
| Bleichroeder LP |
13F
Company
|
0.98%
|
$3,580,000
2,000,000 shares
|
— | 31 Mar 2026 |
| Artia Global Partners LP |
13F
Company
|
0.88%
|
$3,234,421
1,806,939 shares
|
— | 31 Mar 2026 |
| Hennion & Walsh Asset Management, Inc. |
13F
Company
|
0.79%
|
$2,884,930
1,611,693 shares
|
— | 31 Mar 2026 |
| Brown University |
13F
Company
|
0.77%
|
$1,790,000
1,000,000 shares
|
— | 31 Mar 2026 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.61%
|
$2,238,921
1,250,794 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.6%
|
$2,203,520
1,230,409 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.56%
|
$2,053,017
1,146,937 shares
|
— | 31 Mar 2026 |
| MARSHALL WACE, LLP |
13F
Company
|
0.49%
|
$1,811,023
1,011,744 shares
|
— | 31 Mar 2026 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.37%
|
$1,348,607
753,412 shares
|
— | 31 Mar 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.31%
|
$1,123,710
627,771 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
0.27%
|
$996,753
556,845 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.26%
|
$963,684
538,371 shares
|
— | 31 Mar 2026 |
| Woodline Partners LP |
13F
Company
|
0.24%
|
$895,000
500,000 shares
|
— | 31 Mar 2026 |
| MYDA Advisors LLC |
13F
Company
|
0.21%
|
$767,507
428,775 shares
|
— | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.21%
|
$755,204
421,902 shares
|
— | 31 Mar 2026 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.17%
|
$620,024
346,382 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
0.16%
|
$598,837
334,546 shares
|
— | 31 Mar 2026 |
| Amundi |
13F
Individual
|
0.14%
|
$522,157
291,708 shares
|
— | 31 Mar 2026 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.13%
|
$473,070
264,285 shares
|
— | 31 Mar 2026 |
| ExodusPoint Capital Management, LP |
13F
Company
|
0.12%
|
$455,292
254,353 shares
|
— | 31 Mar 2026 |
| NORTHERN TRUST CORP |
13F
Company
|
0.12%
|
$432,428
241,580 shares
|
— | 31 Mar 2026 |
| Squarepoint Ops LLC |
13F
Company
|
0.1%
|
$377,882
211,107 shares
|
— | 31 Mar 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.1%
|
$366,034
204,488 shares
|
— | 31 Mar 2026 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.1%
|
$364,000
203,226 shares
|
— | 31 Mar 2026 |
| BARCLAYS PLC |
13F
Company
|
0.07%
|
$261,849
146,284 shares
|
— | 31 Mar 2026 |
| Virtus Investment Advisers, LLC |
13F
Company
|
0.06%
|
$220,865
123,388 shares
|
— | 31 Mar 2026 |
| HRT FINANCIAL LP |
13F
Company
|
0.06%
|
$212,000
118,981 shares
|
— | 31 Mar 2026 |
| Voleon Capital Management LP |
13F
Company
|
0.05%
|
$183,829
102,698 shares
|
— | 31 Mar 2026 |
| Susquehanna Portfolio Strategies, LLC |
13F
Company
|
0.05%
|
$174,307
97,378 shares
|
— | 31 Mar 2026 |
| EntryPoint Capital, LLC |
13F
Company
|
0.04%
|
$148,323
82,862 shares
|
— | 31 Mar 2026 |
| OMERS ADMINISTRATION Corp |
13F
Company
|
0.03%
|
$121,541
67,900 shares
|
— | 31 Mar 2026 |
| Point72 Asset Management, L.P. |
13F
Company
|
0.03%
|
$117,385
65,578 shares
|
— | 31 Mar 2026 |
| Brevan Howard Capital Management LP |
13F
Company
|
0.03%
|
$114,834
64,153 shares
|
— | 31 Mar 2026 |
| Hudson Bay Capital Management LP |
13F
Company
|
0.03%
|
$111,130
62,084 shares
|
— | 31 Mar 2026 |
| Jain Global LLC |
13F
Company
|
0.03%
|
$91,836
51,305 shares
|
— | 31 Mar 2026 |
| CITIGROUP INC |
13F
Company
|
0.02%
|
$88,397
49,384 shares
|
— | 31 Mar 2026 |
| Diametric Capital, LP |
13F
Company
|
0.02%
|
$85,610
47,827 shares
|
— | 31 Mar 2026 |
| Catalyst Funds Management Pty Ltd |
13F
Company
|
0.02%
|
$85,562
47,800 shares
|
— | 31 Mar 2026 |
| Jefferies Financial Group Inc. |
13F
Company
|
0.02%
|
$83,052
46,398 shares
|
— | 31 Mar 2026 |
| Vanguard Global Advisers, LLC |
13F
Company
|
0.02%
|
$60,992
34,074 shares
|
— | 31 Mar 2026 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
0.02%
|
$58,791
32,845 shares
|
— | 31 Mar 2026 |
| Virtus Family Office LLC |
13F
Company
|
0.01%
|
$49,225
27,500 shares
|
— | 31 Mar 2026 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.01%
|
$36,586
20,439 shares
|
— | 31 Mar 2026 |
| Jump Financial, LLC |
13F
Company
|
0.01%
|
$33,187
18,540 shares
|
— | 31 Mar 2026 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Control Empresarial de Capitales S.A. de C.V. | PROK | Class A Common Shares (as defined in Exhibit 99.1 hereto) | Conversion of derivative security | 588.6% | 63,118,645 | 73,842,723 | 28 Apr 2026 | Direct | ||
| Control Empresarial de Capitales S.A. de C.V. | PROK | Common Units in ProKidney LLC | Conversion of derivative security | -100% | -63,118,645 | 0 | 28 Apr 2026 | Direct | ||
| Control Empresarial de Capitales S.A. de C.V. | PROK | Class B Common Shares | Conversion of derivative security | -100% | -63,118,645 | 0 | 28 Apr 2026 | Direct | ||
| James Coulston | PROK | Employee stock option (right to buy) | Award | 600,000 | 600,000 | 01 Mar 2026 | Direct | |||
| Darin J. Weber | PROK | Employee stock option (right to buy) | Award | 400,000 | 400,000 | 01 Mar 2026 | Direct | |||
| Todd C. Girolamo | PROK | Employee stock option (right to buy) | Award | 600,000 | 600,000 | 01 Mar 2026 | Direct | |||
| Bruce Culleton | PROK | Employee stock option (right to buy) | Award | 3,000,000 | 3,000,000 | 01 Mar 2026 | Direct | |||
| Brian Jg Pereira | PROK | Class A Common Stock | Sale | -100% | $128,769 | $2.37 | -54,333 | 0 | 13 Nov 2025 | Brian J. G. Pereira 2004 Trust |
| Brian Jg Pereira | PROK | Class A Common Stock | Sale | -100% | $1,061,293 | $2.37 | -447,803 | 0 | 13 Nov 2025 | By Brian J. G. Pereira 2012 Irrevocable Trust |
| Brian Jg Pereira | PROK | Class A Common Stock | Sale | -33.7% | $75,152 | $2.72 | -27,595 | 54,333 | 12 Nov 2025 | Brian J. G. Pereira 2004 Trust |
| Brian Jg Pereira | PROK | Class A Common Stock | Sale | -33.7% | $619,363 | $2.72 | -227,431 | 447,803 | 12 Nov 2025 | By Brian J. G. Pereira 2012 Irrevocable Trust |
| Darin J. Weber | PROK | Class A Common Stock | Sale | -100% | -103,480 | 0 | 08 Jul 2025 | Direct | ||
| Pablo G. Legorreta | PROK | Class A Ordinary Shares | Other | -14.5% | -3,823,996 | 22,617,909 | 03 Jun 2025 | See footnote | ||
| Pablo G. Legorreta | PROK | Class A Ordinary Shares | Conversion of derivative security | 16.9% | 3,823,996 | 26,441,905 | 03 Jun 2025 | See footnote | ||
| Pablo G. Legorreta | PROK | Common Units in ProKidney LP | Conversion of derivative security | -4.34% | -3,823,996 | 84,283,430 | 03 Jun 2025 | See footnote | ||
| Pablo G. Legorreta | PROK | Class B Ordinary Shares | Conversion of derivative security | -4.34% | -3,823,996 | 84,283,430 | 03 Jun 2025 | See footnote | ||
| Pablo G. Legorreta | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| Uma Sinha | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| Brian Jg Pereira | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| Santos Jose Ignacio Jimenez | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| Jennifer A. Fox | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| William F. Doyle | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct | |||
| Alan Lotvin | PROK | Director stock option (right to buy) | Award | 125,862 | 125,862 | 29 May 2025 | Direct |